ALLIANCEBERNSTEIN L.P. - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 96 filers reported holding SPERO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$113,000
-45.4%
12,9340.0%0.00%
Q4 2021$207,000
-5.9%
12,934
+8.4%
0.00%
Q3 2021$220,000
+10.6%
11,934
-16.2%
0.00%
Q2 2021$199,000
+25.2%
14,234
+31.4%
0.00%
Q1 2021$159,000
-24.3%
10,8340.0%0.00%
Q4 2020$210,000
+47.9%
10,834
-14.9%
0.00%
Q3 2020$142,000
-17.4%
12,7340.0%0.00%
Q2 2020$172,00012,7340.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,376,968$14,596,00024.02%
Aquilo Capital Management, LLC 1,154,356$12,236,0008.62%
VHCP Management II, LLC 474,015$5,025,0001.92%
AWM Investment Company, Inc. 598,315$6,342,0001.35%
BVF INC/IL 939,704$9,961,0001.05%
Novo Holdings A/S 465,983$4,939,0000.85%
Alphabet Inc. 1,112,473$11,792,0000.35%
Artal Group S.A. 540,000$5,724,0000.23%
Rock Springs Capital Management LP 525,000$5,565,0000.22%
DAFNA Capital Management LLC 39,395$418,0000.16%
View complete list of SPERO THERAPEUTICS INC shareholders